Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Project Oncology®Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
MIRASOL Insights in PROC: A Biomarker-Driven Approach
Project Oncology®MIRASOL Insights in PROC: A Biomarker-Driven Approach
Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
Project Oncology®Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
Medical Industry FeatureManaging Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
- advertisement
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®The Epigenetics of Lung Cancer Dormancy and Relapse
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Project Oncology®How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
- advertisement
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
CME/CEHER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Dialogue with the Experts: Best Practices in NSCLC
CME/CEDialogue with the Experts: Best Practices in NSCLC
- 04/02/2026
- 04/01/2026
- 04/01/2026
- 04/01/2026
- 04/01/2026
- 03/30/2026